Concept information
Preferred term
BNT162 Vaccine
Type
-
mesh:Descriptor
Definition
- mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech.
Broader concept
Entry terms
- 5085ZFP6SJ
- 6FH8H9CL41
- COVID-19 Vaccine Pfizer-BioNTech
- JV8KBX6XZG
- N38TVC63NU
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- biosynthesis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
In other languages
-
French
-
5085ZFP6SJ
-
6FH8H9CL41
-
JV8KBX6XZG
-
N38TVC63NU
-
Vaccin Pfizer-BioNTech contre la COVID-19
URI
http://data.loterre.fr/ark:/67375/JVR-BR976QH6-6
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}